[HTML][HTML] SARS-CoV-2 reinfections: Overview of efficacy and duration of natural and hybrid immunity
S Pilz, V Theiler-Schwetz, C Trummer, R Krause… - Environmental …, 2022 - Elsevier
Seroprevalence surveys suggest that more than a third and possibly more than half of the
global population has been infected with SARS-CoV-2 by early 2022. As large numbers of
people continue to be infected, the efficacy and duration of natural immunity in terms of
protection against SARS-CoV-2 reinfections and severe disease is of crucial significance for
the future. This narrative review provides an overview on epidemiological studies
addressing this issue. National surveys covering 2020–2021 documented that a previous …
global population has been infected with SARS-CoV-2 by early 2022. As large numbers of
people continue to be infected, the efficacy and duration of natural immunity in terms of
protection against SARS-CoV-2 reinfections and severe disease is of crucial significance for
the future. This narrative review provides an overview on epidemiological studies
addressing this issue. National surveys covering 2020–2021 documented that a previous …
